139 related articles for article (PubMed ID: 17327692)
1. Optimization of an animal test protocol for toxicogenomics studies (ii); a cross-laboratory gene expression analysis.
Sumida K; Saito K; Oeda K; Otsuka M; Tsujimura K; Miyaura H; Sekijima M; Nakayama K; Kawano Y; Kawakami Y; Asamoto M; Shirai T
J Toxicol Sci; 2007 Feb; 32(1):33-45. PubMed ID: 17327692
[TBL] [Abstract][Full Text] [Related]
2. Optimization of an animal test protocol for toxicogenomics studies (I); requirement study of a protocol.
Sumida K; Saito K; Oeda K; Otsuka M; Tsujimura K; Miyaura H; Sekijima M; Nakayama K; Kawano Y; Kawakami Y; Asamoto M; Shirai T
J Toxicol Sci; 2007 Feb; 32(1):19-32. PubMed ID: 17327691
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of DNA microarray results in the Toxicogenomics Project (TGP) consortium in Japan.
Noriyuki N; Igarashi Y; Ono A; Yamada H; Ohno Y; Urushidani T
J Toxicol Sci; 2012; 37(4):791-801. PubMed ID: 22863858
[TBL] [Abstract][Full Text] [Related]
4. Comparing next-generation sequencing and microarray technologies in a toxicological study of the effects of aristolochic acid on rat kidneys.
Su Z; Li Z; Chen T; Li QZ; Fang H; Ding D; Ge W; Ning B; Hong H; Perkins RG; Tong W; Shi L
Chem Res Toxicol; 2011 Sep; 24(9):1486-93. PubMed ID: 21834575
[TBL] [Abstract][Full Text] [Related]
5. Inter-laboratory study of human in vitro toxicogenomics-based tests as alternative methods for evaluating chemical carcinogenicity: a bioinformatics perspective.
Herwig R; Gmuender H; Corvi R; Bloch KM; Brandenburg A; Castell J; Ceelen L; Chesne C; Doktorova TY; Jennen D; Jennings P; Limonciel A; Lock EA; McMorrow T; Phrakonkham P; Radford R; Slattery C; Stierum R; Vilardell M; Wittenberger T; Yildirimman R; Ryan M; Rogiers V; Kleinjans J
Arch Toxicol; 2016 Sep; 90(9):2215-2229. PubMed ID: 26525393
[TBL] [Abstract][Full Text] [Related]
6. Inter- and intra-laboratory study to determine the reproducibility of toxicogenomics datasets.
Scott DJ; Devonshire AS; Adeleye YA; Schutte ME; Rodrigues MR; Wilkes TM; Sacco MG; Gribaldo L; Fabbri M; Coecke S; Whelan M; Skinner N; Bennett A; White A; Foy CA
Toxicology; 2011 Nov; 290(1):50-8. PubMed ID: 21871943
[TBL] [Abstract][Full Text] [Related]
7. Sources of variation in baseline gene expression levels from toxicogenomics study control animals across multiple laboratories.
Boedigheimer MJ; Wolfinger RD; Bass MB; Bushel PR; Chou JW; Cooper M; Corton JC; Fostel J; Hester S; Lee JS; Liu F; Liu J; Qian HR; Quackenbush J; Pettit S; Thompson KL
BMC Genomics; 2008 Jun; 9():285. PubMed ID: 18549499
[TBL] [Abstract][Full Text] [Related]
8. Toxicogenomics in the assessment of immunotoxicity.
Baken KA; Vandebriel RJ; Pennings JL; Kleinjans JC; van Loveren H
Methods; 2007 Jan; 41(1):132-41. PubMed ID: 17161310
[TBL] [Abstract][Full Text] [Related]
9. Assessing compound carcinogenicity in vitro using connectivity mapping.
Caiment F; Tsamou M; Jennen D; Kleinjans J
Carcinogenesis; 2014 Jan; 35(1):201-7. PubMed ID: 23940306
[TBL] [Abstract][Full Text] [Related]
10. Rat toxicogenomic study reveals analytical consistency across microarray platforms.
Guo L; Lobenhofer EK; Wang C; Shippy R; Harris SC; Zhang L; Mei N; Chen T; Herman D; Goodsaid FM; Hurban P; Phillips KL; Xu J; Deng X; Sun YA; Tong W; Dragan YP; Shi L
Nat Biotechnol; 2006 Sep; 24(9):1162-9. PubMed ID: 17061323
[TBL] [Abstract][Full Text] [Related]
11. In pursuit of effective toxicogenomics.
Gant TW; Zhang SD
Mutat Res; 2005 Aug; 575(1-2):4-16. PubMed ID: 15885710
[TBL] [Abstract][Full Text] [Related]
12. An improved model of predicting hepatocarcinogenic potential in rats by using gene expression data.
Yamada F; Sumida K; Saito K
J Appl Toxicol; 2016 Feb; 36(2):296-308. PubMed ID: 26198598
[TBL] [Abstract][Full Text] [Related]
13. Practical application of toxicogenomics for profiling toxicant-induced biological perturbations.
Kiyosawa N; Manabe S; Yamoto T; Sanbuissho A
Int J Mol Sci; 2010 Sep; 11(9):3397-412. PubMed ID: 20957103
[TBL] [Abstract][Full Text] [Related]
14. Cross-platform toxicogenomics for the prediction of non-genotoxic hepatocarcinogenesis in rat.
Römer M; Eichner J; Metzger U; Templin MF; Plummer S; Ellinger-Ziegelbauer H; Zell A
PLoS One; 2014; 9(5):e97640. PubMed ID: 24830643
[TBL] [Abstract][Full Text] [Related]
15. Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver.
Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
Arch Toxicol; 2012 Sep; 86(9):1399-411. PubMed ID: 22484513
[TBL] [Abstract][Full Text] [Related]
16. Cross-species comparative toxicogenomics as an aid to safety assessment.
Mattes WB
Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):859-74. PubMed ID: 17125406
[TBL] [Abstract][Full Text] [Related]
17. Toxicogenomics applied to in vitro carcinogenicity testing with Balb/c 3T3 cells revealed a gene signature predictive of chemical carcinogens.
Rohrbeck A; Salinas G; Maaser K; Linge J; Salovaara S; Corvi R; Borlak J
Toxicol Sci; 2010 Nov; 118(1):31-41. PubMed ID: 20713471
[TBL] [Abstract][Full Text] [Related]
18. Development of a toxicogenomics signature for genotoxicity using a dose-optimization and informatics strategy in human cells.
Li HH; Hyduke DR; Chen R; Heard P; Yauk CL; Aubrecht J; Fornace AJ
Environ Mol Mutagen; 2015 Jul; 56(6):505-19. PubMed ID: 25733355
[TBL] [Abstract][Full Text] [Related]
19. A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats.
Uehara T; Hirode M; Ono A; Kiyosawa N; Omura K; Shimizu T; Mizukawa Y; Miyagishima T; Nagao T; Urushidani T
Toxicology; 2008 Aug; 250(1):15-26. PubMed ID: 18619722
[TBL] [Abstract][Full Text] [Related]
20. A toxicogenomic approach for the prediction of murine hepatocarcinogenesis using ensemble feature selection.
Eichner J; Kossler N; Wrzodek C; Kalkuhl A; Bach Toft D; Ostenfeldt N; Richard V; Zell A
PLoS One; 2013; 8(9):e73938. PubMed ID: 24040119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
